George Calin Highlighted a Study on CRISPR as a Therapeutic Tool for Retinal Degenerations
George Calin/LinkedIn

George Calin Highlighted a Study on CRISPR as a Therapeutic Tool for Retinal Degenerations

George Calin, Professor at MD Anderson Cancer Center, shared a post on LinkedIn:

“Just published in Molecular Aspects of Medicine (Elsevier):

ENJOY Science & enjoy reading this excellent review by Kinga Bujakowska and colleagues!”

Title: CRISPR as a therapeutic tool for inherited retinal degenerations: Advances, challenges, and future directions

Authors: Egle Galdikaite-Braziene, Raulas Krušnauskas, Emiline Henderson, Kinga M. Bujakowska

Read the Full Article.

George Calin Highlighted a Study on CRISPR as a Therapeutic Tool for Retinal Degenerations

Other articles featuring George Calin on OncoDaily.